Filing Details
- Accession Number:
- 0000200406-25-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-18 21:33:38
- Reporting Period:
- 2025-02-13
- Filing Date:
- 2025-02-18
- Accepted Time:
- 2025-02-18 21:33:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1998491 | Timothy Schmid | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Evp, Ww Chair, Medtech | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-13 | 499 | $0.00 | 13,539 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-14 | 193 | $155.26 | 13,346 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2025-02-14 | 1,765 | $0.00 | 15,111 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-14 | 639 | $156.71 | 14,472 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2025-02-15 | 1,029 | $0.00 | 15,501 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-18 | 403 | $156.15 | 15,098 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Share Units | Disposition | 2025-02-13 | 499 | $0.00 | 499 | $0.00 |
| Common Stock | Restricted Share Units | Disposition | 2025-02-14 | 1,765 | $0.00 | 1,765 | $0.00 |
| Common Stock | Restricted Share Units | Disposition | 2025-02-15 | 1,029 | $0.00 | 1,029 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 499 | No | 4 | M | Direct | ||
| 0 | 2025-02-14 | No | 4 | M | Direct | |
| 2,056 | No | 4 | M | Direct |
Footnotes
- Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
- Shares withheld for payment of taxes upon vesting of RSUs.
- Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting.
- Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
- Each RSU represents a contingent right to receive one share of Company Common Stock.
Billionaire Hedge Funds
